A new Korean government-backed study titled, Mortality in severe serious adverse events following heterologous and homologous prime-boost vaccination strategies for SARS-CoV-2: A retrospective cohort study, was just published in the journal PLoS One:
Click Here to Learn More
Global
© Prepping Communities. This content is for informational purposes only and not professional advice. Use at your own risk.
Terms | Privacy | Guidelines